Table 1. Results of MERS coronavirus testing of 77 travelers from the Middle East to England by key clinical and epidemiologic characteristics where information available, September 2012–October 2013.
| Characteristics | No. tested | No. (%) MERS coronavirus–positive |
|---|---|---|
| Age group, y | ||
| 0–4 | 5 | 0 |
| 5–17 | 1 | 0 |
| 18–44 | 10 | 0 |
| 45–64 | 34 | 2 (6) |
| ≥65 | 25 | 0 |
| Unknown | 2 | 0 |
| Sex | ||
| M | 49 | 2 (4) |
| F | 26 | 0 |
| Unknown | 2 | 0 |
| Clinical history | ||
| Fever | 51 | 2 (4) |
| Cough | 51 | 2 (4) |
| Pulmonary parenchymal involvement | 34 | 2 (6) |
| Acute respiratory distress syndrome | 7 | 2 (29) |
| Mechanical ventilation | 15 | 2 (13) |
| Extracorporeal membrane oxygenation | 2 | 2 (100) |
|
|
|
|
| Travel history in exposure period* before symptom onset† | ||
| Israel | 1 | 0 |
| Jordan | 1 | 0 |
| Kingdom of Saudi Arabia | 40 | 1 (3) |
| Qatar | 7 | 1 (14) |
| United Arab Emirates | 27 | 0 |
| Yemen | 1 | 0 |
*Exposure period was 10 days until June 2013, when it was increased to 14 days. †Some patients had also traveled to countries outside the Middle East.